• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 10
  3. Author

Online ISSN: 2515-8260

Volume7, Issue10

A study to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.

    Dr. Gaurav, Dr. Kamalkant Harishankar Singh

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 10, Pages 4368-4373

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.
Materials and methods: The present observational study was conducted in the department of Urology, Indira Gandhi Institute of Medical Sciences Sheikhpura, Patna, from January 2018 - June 2019 among 120 patients diagnosed with BHP. Patients diagnosed with symptomatic BPH and willing for medical treatment were included in this study. Patients received either of following medical treatment: Tamsulosin 0.4 mg once a day (qd),/Silodosin 4-8 mg qd,/Alfuzosin SR 10 mg qd,/combination of Dutasteride 0.5 mg PO qd and Silodosin 4-8 mg qd
Results: Out of total 120; 7 were given Alfuzosin; 24 were treated with Tamsulosin; 41 were with Silodosin and rest 48 were given combination of Silodosin & dutasteride. 2 patients couldn’t have sexual intercourse due to ED. 8 out of the 39 patients (20.5%) treated with silodosin 8mg who could have sexual intercourse., complained of EjD.3 out of the 41 patients (7.3%) treated with silodosin and dutasteride, who could have sexual intercourse could not achieve orgasm.
Conclusion: The incidence of sexual dysfunction is least with Alfuzosin. Among drug treatment-combination therapy is associated with maximum incidence of sexual dysfunction in comparison to drugs used alone.
Keywords:
  • PDF (142 K)
  • XML
(2021). A study to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.. European Journal of Molecular & Clinical Medicine, 7(10), 4368-4373.
Dr. Gaurav, Dr. Kamalkant Harishankar Singh. "A study to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.". European Journal of Molecular & Clinical Medicine, 7, 10, 2021, 4368-4373.
(2021). 'A study to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.', European Journal of Molecular & Clinical Medicine, 7(10), pp. 4368-4373.
A study to assess the incidence of sexual side effects following medical treatment of BPH in Indian population.. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 4368-4373.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 58
  • PDF Download: 94
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus